Author Archives: David C. Whitcomb, Celeste Shelton, Randall E. Brand
Genetics and Genetic Testing in Pancreatic Cancer
Genetic testing of germline DNA is used in patients suspected of being at risk of pancreatic ductal adenocarcinoma (PDAC) to better define the individual’s risk and to determine the mechanism of risk. A high genetic risk increases the pretest probabi… Continue reading
Posted in News
Comments Off on Genetics and Genetic Testing in Pancreatic Cancer